|
GDUFA Goals Include Complete Response Letter Meetings, QbD for Generics
The FDA has agreed to schedule 30-minute teleconferences with generic-drug makers upon request to discuss complete response letters under the proposed Generic Drug User Fee Act (GDUFA) goals letter.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives